Organogenesis Holdings, Inc. (ORGO)
1.33
-0.07
(-5.00%)
USD |
NASDAQ |
Oct 02, 16:00
1.325
0.00 (0.00%)
After-Hours: 20:00
Organogenesis Holdings Profit Margin (Quarterly) : -220.0% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -220.0% |
| March 31, 2026 | -142.8% |
| December 31, 2025 | 19.37% |
| September 30, 2025 | 14.30% |
| June 30, 2025 | -9.30% |
| March 31, 2025 | -21.74% |
| December 31, 2024 | 6.06% |
| September 30, 2024 | 10.71% |
| June 30, 2024 | -13.09% |
| March 31, 2024 | -1.91% |
| December 31, 2023 | -0.57% |
| September 30, 2023 | 2.92% |
| June 30, 2023 | 4.53% |
| March 31, 2023 | -2.76% |
| December 31, 2022 | 6.48% |
| September 30, 2022 | 0.18% |
| Date | Value |
|---|---|
| June 30, 2022 | 7.20% |
| March 31, 2022 | -0.94% |
| December 31, 2021 | 39.88% |
| September 30, 2021 | 11.06% |
| June 30, 2021 | 16.79% |
| March 31, 2021 | 9.70% |
| December 31, 2020 | 17.15% |
| September 30, 2020 | 20.59% |
| June 30, 2020 | -7.49% |
| March 31, 2020 | -26.43% |
| December 31, 2019 | -5.89% |
| September 30, 2019 | -16.71% |
| June 30, 2019 | -14.86% |
| March 31, 2019 | -27.42% |
| December 31, 2018 | -14.55% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| cbdMD, Inc. | -20.30% |
| Guardian Pharmacy Services, Inc. | 6.29% |
| ACADIA Pharmaceuticals, Inc. | 10.23% |
| Agenus, Inc. | -1.64% |
| Alnylam Pharmaceuticals, Inc. | 12.74% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -22.74% |
| Return on Assets | -16.86% |
| Return on Invested Capital | -19.55% |
| Gross Profit Margin (Quarterly) | 30.84% |
| Operating Margin (Quarterly) | -107.6% |
| Return on Net Operating Assets | -22.99% |